136 related articles for article (PubMed ID: 9760691)
1. Discovery of bioavailable inhibitors of secretory phospholipase A2.
Blanchard SG; Andrews RC; Brown PJ; Gan LS; Lee FW; Sinhababu AK; Wheeler TN
Pharm Biotechnol; 1998; 11():445-63. PubMed ID: 9760691
[TBL] [Abstract][Full Text] [Related]
2. Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.
Nataraju A; Raghavendra Gowda CD; Rajesh R; Vishwanath BS
Curr Top Med Chem; 2007; 7(8):801-9. PubMed ID: 17456043
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of tricyclic dipyrido diazepinone derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
Thimmegowda NR; Dharmappa KK; Kumar CS; Sadashiva MP; Sathish AD; Nanda BL; Vishwanath BS; Rangappa KS
Curr Top Med Chem; 2007; 7(8):811-20. PubMed ID: 17456044
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
Fleisch JH; Armstrong CT; Roman CR; Mihelich ED; Spaethe SM; Jackson WT; Bobbitt JL; Draheim S; Bach NJ; Dillard RD; Martinelli M; Fouts R; Snyder DW
J Pharmacol Exp Ther; 1996 Jul; 278(1):252-7. PubMed ID: 8764358
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
[TBL] [Abstract][Full Text] [Related]
7. 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors.
Aitdafoun M; Mounier C; Heymans F; Binisti C; Bon C; Godfroid JJ
Biochem Pharmacol; 1996 Mar; 51(6):737-42. PubMed ID: 8602868
[TBL] [Abstract][Full Text] [Related]
8. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
Tanaka K; Arita H
Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
[TBL] [Abstract][Full Text] [Related]
9. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
[TBL] [Abstract][Full Text] [Related]
10. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity.
Gil B; Sanz MJ; Terencio MC; Gunasegaran R; Payá M; Alcaraz MJ
Biochem Pharmacol; 1997 Mar; 53(5):733-40. PubMed ID: 9113093
[TBL] [Abstract][Full Text] [Related]
11. Functional site of endogenous phospholipase A2 inhibitor from python serum.
Thwin MM; Satish RL; Chan ST; Gopalakrishnakone P
Eur J Biochem; 2002 Jan; 269(2):719-27. PubMed ID: 11856333
[TBL] [Abstract][Full Text] [Related]
12. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ
Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors.
Chen X; Xu W; Wang K; Mo M; Zhang W; Du L; Yuan X; Xu Y; Wang Y; Shen J
J Med Chem; 2015 Nov; 58(21):8529-41. PubMed ID: 26479945
[TBL] [Abstract][Full Text] [Related]
14. Suppression of acute experimental inflammation by antisense oligonucleotides targeting secretory phospholipase A2 (sPLA2) in vitro and in vivo experiments.
Tibes U; Röhr SP; Scheuer W; Amandi-Burgermeister E; Litters A
Adv Exp Med Biol; 1999; 469():199-207. PubMed ID: 10667331
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
OmPraba G; Velmurugan D
Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sPLA
Jayachandra K; Gowda MDM; Rudresha GV; Manjuprasanna VN; Urs AP; Nandana MB; Bharatha M; Jameel NM; Vishwanath BS
J Cell Biochem; 2023 Feb; 124(2):294-307. PubMed ID: 36585945
[TBL] [Abstract][Full Text] [Related]
17. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of secretory phospholipase A2 group IIA.
Reid RC
Curr Med Chem; 2005; 12(25):3011-26. PubMed ID: 16378502
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of benzophenone oxime analogues as inhibitor of secretory phospholipase A(2) with anti-inflammatory activity.
Murari SK; Sriharsha SN; Shashikanth S; Vishwanath BS
Bioorg Med Chem Lett; 2004 May; 14(10):2423-5. PubMed ID: 15109625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
